Cytovance recently appeared on the Outsourced Pharma Large Molecule Capabilities Update to share how our available capacity, experince in microbial and mammalian expression systems, US-based manufacturing facilities, and high scale-up success rate are helping industry customers meet product milestones.
View the video below to hear from Stijn Cattaert, our Director of Business Development, on the agility and experience that make Team Cytovance the ideal CDMO partner for your clinical and commercial programs.